
    
      Radiotherapy will last for 6 weeks. During planning of treatment, regimen and average dose to
      the whole bladder will be recorded to assess the impact of EBRT on urinary symptoms.

      The treated-group will receive also intravesical Ialuril速 weekly for 6 weeks (in the 24 hours
      before every radiation therapy weekly schedule), plus oral treatment with Ialuril速 Soft Gels
      capsules (1 capsule twice a day after meals, at a distance of 12 hours, for 12 weeks).

      The control-group will receive radiotherapy only for 6 weeks.

      The Primary Objective is to assess the tolerability and safety of HA-CS intravesical
      instillations (Ialuril速) plus an oral combination of curcumin, quercetin, HA and CS (Ialuril速
      Soft Gels) in male patients undergoing radiotherapy for prostate cancer The efficacy of the
      treatment will be evaluated at the end of the study once received all the crfs.
    
  